Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
260.50
-5.5 (-2.07%)
BSENSE

Jun 18

BSE+NSE Vol: 80.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kopran
Wanbury
Lincoln Pharma.
Anlon Healthcare
Bajaj Healthcare
Anuh Pharma
Themis Medicare
Bharat Parenter.
Fermenta Biotec.
Remus Pharma.
Accent Microcell
Why is Wanbury Ltd ?
1
High Debt Company with a Debt to Equity ratio (avg) at 3.36 times
  • Poor long term growth as Net Sales has grown by an annual rate of 10.62% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 3.36 times
2
Healthy long term growth as Operating profit has grown by an annual rate 62.06%
3
The company has declared Positive results for the last 3 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 3.70 times
  • PBDIT(Q) Highest at Rs 29.85 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 18.14%
4
Stock is technically in a Mildly Bullish range
  • The stocks MACD and KST technical factors are also Bullish
5
With ROCE of 33.3, it has a Attractive valuation with a 4.9 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -11.39%, its profits have risen by 128.3% ; the PEG ratio of the company is 0.2
6
86.69% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Wanbury should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Wanbury for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Wanbury
-11.39%
-0.22
52.75%
Sensex
-5.14%
-0.39
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.62%
EBIT Growth (5y)
62.06%
EBIT to Interest (avg)
1.29
Debt to EBITDA (avg)
2.17
Net Debt to Equity (avg)
2.77
Sales to Capital Employed (avg)
2.95
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
86.69%
Institutional Holding
0.59%
ROCE (avg)
30.89%
ROE (avg)
42.23%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
22
Industry P/E
34
Price to Book Value
15.68
EV to EBIT
14.71
EV to EBITDA
12.43
EV to Capital Employed
4.90
EV to Sales
1.74
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
33.30%
ROE (Latest)
72.53%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 3.70 times

PBDIT(Q)

Highest at Rs 29.85 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 18.14%

PBT LESS OI(Q)

Highest at Rs 18.56 cr.

PAT(Q)

Highest at Rs 25.30 cr.

EPS(Q)

Highest at Rs 6.21

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Wanbury
Operating Profit to Interest - Quarterly
Highest at 3.70 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit After Tax (PAT) - Quarterly
At Rs 25.30 cr has Grown at 56.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 16.17 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 29.85 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 18.14%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 18.56 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 18.56 cr has Grown at 21.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 15.28 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 25.30 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 6.21
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)